CLINICAL_TRIALS
withdrawal
· 2017-01-12
Clinical Trial Update: Pemoline in the Treatment of Stimulant Dependence - 5 [Phase 2]
Summary
A Phase 2 clinical trial evaluating pemoline for cocaine-related disorders was withdrawn (sponsor: National Institute on Drug Abuse).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: WITHDRAWN